Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

Biotechnology

Healthcare
$4.16 +2.94%

+$0.14 today

Market cap
$120.02M
Beta
0.29
P/E (TTM)
-3.0
EPS (TTM)
-$1.66
52W Low $3.20High $12.99

Volume 0.27M

Average 0.08M

NTHI Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Neonc Technologies Holdings, Inc.NASDAQ: NTHI

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development grows 28.9% year over year

Q1 FY2026 research & development of $1.29M rose 28.9% year over year. Sequentially, it rose 3.1% from the prior quarter.

Context

  • Research & development amounted to 9097.9% of revenue in FY2025.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.29M+3.1% QoQ
Last fiscal yearDec 2025
$3.64M— YoY
LTMMar 2026
$3.93M— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+28.9%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
3.64M USD
Year-over-year change
—

Research & Development vs competitors

How NTHI compares with its peers on the latest reported figures

No competitor Research & Development figures are available to compare.

Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

Intrinsic Alpha fair value

Locked

Current Price

$4.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.